CATALENT, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.34 USD | +0.16% |
|
-0.78% | +23.25% |
| 16/05 | Argus Downgrades Catalent to Sell From Buy | MT |
| 14/05 | Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 999.91Cr | - | |||||
| 69TCr | ||||||
| 59TCr | ||||||
| 37TCr | ||||||
| 33TCr | ||||||
| 29TCr |
- Stock Market
- Equities
- CTLT Stock
- Charts Catalent, Inc.
- Sector Chart